How to buy Respiri shares
Own Respiri shares in just a few minutes.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Respiri Limited is a medical devices business based in Australia. Respiri shares (RSH) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Respiri has a trailing 12-month revenue of around $1.2 million.
How to buy shares in Respiri
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Respiri . Find the share by name or ticker symbol: RSH. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Respiri reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Respiri . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Respiri share priceUse our graph to track the performance of RSH stocks over time.
Respiri shares at a glance
|52-week range||$0.059 - $0.25|
|50-day moving average||$0.1329|
|200-day moving average||$0.1643|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.017|
Compare share trading platforms
Is it a good time to buy Respiri stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|Revenue TTM||$1.2 million|
|Gross profit TTM||$2.2 million|
|Return on assets TTM||-108.65%|
|Return on equity TTM||-219.14%|
|Market capitalisation||$90.3 million|
TTM: trailing 12 months
Respiri share dividends
We're not expecting Respiri to pay a dividend over the next 12 months.
Have Respiri 's shares ever split?
Respiri 's shares were split on a 1:20 basis on 30 July 2012. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Respiri shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Respiri shares which in turn could have impacted Respiri 's share price.
Respiri share price volatility
Over the last 12 months, Respiri 's shares have ranged in value from as little as $0.059 up to $0.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Respiri 's is -0.2043. This would suggest that Respiri 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Respiri has bucked the trend.
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; and Wholter, a device for home ambulatory recording of nocturnal wheeze and cough. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
Frequently asked questions
More guides on Finder
How to buy Robinhood stock from Australia
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
How to build a DIY Raspberry Pi arcade machine for retro gaming
We explain everything you need to make your own retro arcade machine, built around the super-flexible Raspberry Pi.
International money transfer services
Beat the banks, find the best exchange rates and avoid fees when you send money abroad from Australia.
How to sell shares in Australia
All the key info you need to know to sell shares you inherited or received as a gift.
How to buy Roblox (RBLX) shares from Australia
Steps to owning and managing Roblox shares.
How to invest in the Deliveroo IPO from Australia
Everything we know about the Deliveroo IPO, plus information on how to buy in.
How to buy Respiri shares
Steps to owning and managing Zebit shares.
How to buy Respiri shares
Steps to owning and managing CleanSpace shares.
Ask an Expert